Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Author:

Rodolphi Cinthia Magalhães1,Soares Isabela Ferreira2,Matos Ada da Silva2,Rodrigues-da-Silva Rodrigo Nunes3ORCID,Ferreira Marcelo Urbano4,Pratt-Riccio Lilian Rose56ORCID,Totino Paulo Renato Rivas56,Scopel Kézia Katiani Gorza1,Lima-Junior Josué da Costa2ORCID

Affiliation:

1. Research Centre of Parasitology, Department of Parasitology, Microbiology and Immunology and Post-Graduation Program in Biological Science, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil

2. Laboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil

3. Laboratory of Hantaviruses and Rickettsioses, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil

4. Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Sao Paulo 05508-220, Brazil

5. Laboratory for Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil

6. Center for Research, Diagnosis, and Training in Malaria of Fiocruz, Rio de Janeiro 21040-900, Brazil

Abstract

Malaria is a serious health problem worldwide affecting mainly children and socially vulnerable people. The biological particularities of P. vivax, such as the ability to generate dormant liver stages, the rapid maturation of gametocytes, and the emergence of drug resistance, have contributed to difficulties in disease control. In this context, developing an effective vaccine has been considered a fundamental tool for the efficient control and/or elimination of vivax malaria. Although recombinant proteins have been the main strategy used in designing vaccine prototypes, synthetic immunogenic peptides have emerged as a viable alternative for this purpose. Considering, therefore, that in the Brazilian endemic population, little is known about the profile of the humoral immune response directed to synthetic peptides that represent different P. vivax proteins, the present work aimed to map the epitope-specific antibodies’ profiles to synthetic peptides representing the linear portions of the ookinete and sporozoite cell passage protein (CelTOS), thrombospondin-related adhesive protein (TRAP), and cysteine-rich protective antigen (CyRPA) proteins in the acute (AC) and convalescent phases (Conv30 and Conv180 after infection) of vivax malaria. The results showed that the studied subjects responded to all proteins for at least six months following infection. For IgM, a few individuals (3–21%) were positive during the acute phase of the disease; the highest frequencies were observed for IgG (28–57%). Regarding the subclasses, IgG2 and IgG3 stood out as the most prevalent for all peptides. During the follow-up, the stability of IgG was observed for all peptides. Only one significant positive correlation was observed between IgM and exposure time. We conclude that for all the peptides, the immunodominant epitopes are recognized in the exposed population, with similar frequency and magnitude. However, if the antibodies detected in this study are potential protectors, this needs to be investigated.

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Programa de Pós-Graduação em Ciências Biológicas of the Universidade Federal de Juiz de Fora

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

FIOCRUZ

CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) Master fellowship

Publisher

MDPI AG

Reference74 articles.

1. WHO (2024, January 15). World Malaria Report 2023a. Available online: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023.

2. De Alvarenga, D.A.M., Rodrigues, D.F., Culleton, R., De Pina-Costa, A., Bianco, C.B., Silva, S., Nunes, A.J.L., De Souza, J.C., Hirano, Z.M.B., and Moreira, S.B. (2018). An assay for the identification of Plasmodium simium infection for diagnosis of zoonotic malaria in the Brazilian Atlantic Forest. Sci. Rep., 8.

3. WHO (2024, January 20). Health Topics—Malaria 2023. Available online: https://www.who.int/health-topics/malaria#tab=tab_1.

4. The Hypnozoite and Relapse in Primate Malaria;Cogswell;Clin. Microbiol. Rev.,1992

5. Why Plasmodium vivax and Plasmodium falciparum are so different? A tale of two clades and their species diversities;Escalante;Malar. J.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3